Our advisors are among the best in the world, enabling CoreMap to deliver a superior solution for AF patients.
The CoreMap team brings scientific rigor and business acumen to everything we do.
John Abele
Advisor
John Abele is an esteemed business leader and innovator with over four decades leading scientific advancement and transforming healthcare through technology.
Mr. Abele is a co-founder of Boston Scientific and has served on many boards from FIRST Robotics to the Rocky Mountain Institute. During his time with Boston Scientific, Mr. Abele pioneered the development of medical devices that would allow for less invasive surgery, with a goal to benefit public health by providing more accessible, lower-cost, and lower-trauma medical treatment options. Mr. Abele is a Fellow in both the Society of Interventional Radiology and the American Institute for Medical and Biomedical Engineering. He holds numerous patents and has published and lectured extensively on the technology of various medical devices and on the technical, social, economic, and political trends and issues affecting healthcare.
Mr. Abele is a graduate of Amherst College in Massachusetts and resides in Vermont.
Hugh Calkins, M.D.
Advisor
Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management.
Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and, arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miller Coulson Academy of Clinical Excellence in 2014.
Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins.
Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He lives in Maryland.
Ken Ellenbogen, M.D.
Advisor
Dr. Ken Ellenbogen is an advisor to the CoreMap team, as well as serving as Chairman of the Division of Cardiology and the Director of Clinical Cardiac Electrophysiology and Pacing at Virginia Commonwealth University.
A native of New York and member of the VCU faculty since 1986, Dr. Ellenbogen achieved the rank of full Professor of Medicine (Cardiology) in 1997 and was Vice-Chairman of the Division of Cardiology from 2003 to 2009. He also serves as Director of Clinical Cardiac Electrophysiology and Pacing at VCU’s MCV Campus. Dr. Ellenbogen's academic, clinical, and research efforts include an interest in newer, more effective ways to perform ablation and to develop methods for ablation of atrial fibrillation. Dr. Ellenbogen has a highly successful record of attracting both public and private funding and has served as principal investigator on over 100 funded grants and contracts.
Dr. Ellenbogen received his undergraduate degree from Princeton University, his medical degree from Johns Hopkins University, completed his residency at Johns Hopkins Hospital, and did his fellowship at the Duke University of Medicine. He lives in Virginia.
Warren M. “Sonny” Jackman, M.D.
Advisor
Dr. Warren “Sonny” Jackman is an advisor to the CoreMap team and noted electrophysiologist and ablation pioneer.
Dr. Jackman practices at the University of Oklahoma Health Sciences Center. He holds the positions of George Lynn Cross Research Professor Emeritus and Co-founder of the Heart Rhythm Institute. His expansive career and innovations in atrial fibrillation earned him many accolades, with many referring to Dr. Jackman as the definitive thought leader on ablation and treatment for AF.
Dr. Jackman obtained his medical degree from the University of Florida and completed his residency in Internal Medicine at Wake Forest University and Cardiology/Electrophysiology Fellowship at Indiana University. He resides in Edmond, OK.
Pierre Jaïs, M.D.
Advisor
Dr. Pierre Jaïs is a Professor at the Cardiology Hospital, Pessac, France in the Rhythmology & Cardiac Stimulation Department. Dr. Jaïs co-manages the LIRYC Institute (Electrophysiology and Heart Modeling Institute) and the MUSIC EQUIPEX; both aim to improve knowledge and treatments of electrical dysfunctions of the heart with an extra focus on imaging for MUSIC.
Dr. Jaïs is a regular contributor to national and international symposia and has written more than 700 papers, mainly on electrophysiology and RF catheter ablation, particularly focusing on atrial arrhythmias. He is currently working on catheter ablation for atrial and ventricular arrhythmias with special focus on advanced imaging integration and modeling to guide ablation procedures.
Dr Jaïs received the "Best Paper Award for Clinical Science" by Circulation in 2009. He was awarded the Lamonica Prize of the Académie des Sciences in 2011, the Robert Debré in 2015, the E.N Pristowski lectureship at HRS 2018 and the Eli Gang most innovative abstract at HRS 2019. He lives in Bordeaux France.
Vivek Reddy, M.D.
Advisor
Vivek Y. Reddy, MD is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and The Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai.
Dr. Reddy is one of the nation’s premier cardiac electrophysiologists, leading a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias – including atrial fibrillation and ventricular tachycardias – heart failure and structural heart disease.
Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured. Under his leadership, Mount Sinai is the lead site on several multinational clinical trials exploring new arrhythmia procedures and technologies.